Patents Assigned to Geneticure Inc.
  • Method for treatment of hypertension
    Patent number: 12351873
    Abstract: The present invention concerns selective renal denervation treatment of drug resistant hypertensive patients by correlating the patients' genetic panel by categorization and hierarchy according to patients' genetic variants within the functional genes for heart activity, for the renin-angiotensin aldosterone system, and for renal activity.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: July 8, 2025
    Assignee: Geneticure Inc.
    Inventors: Eric Snyder, Ryan Sprissler, Benjamin Bowman, Scott C. Snyder
  • Machine assay and analysis for selecting antihypertensive drugs
    Patent number: 11761043
    Abstract: The invention relates to improved methods, devices, and kits for identifying and implementing an appropriate treatment regimen for subjects suffering from hypertension.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: September 19, 2023
    Assignee: Geneticure Inc.
    Inventors: Eric Snyder, Ryan Sprissler, Scott C. Snyder
  • Therapeutic regimen for hypertension
    Patent number: 11674179
    Abstract: The invention relates to improved methods, devices, and kits for identifying and implementing an appropriate treatment regimen for subjects suffering from hypertension.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: June 13, 2023
    Assignee: Geneticure Inc.
    Inventors: Eric Snyder, Ryan Sprissler, Scott C. Snyder